Liver Transplantation

Copyright © 2012 American Association for the Study of Liver Diseases

Cover image for Vol. 17 Issue S3

Supplement: Liver Transplant Immunosuppression: “Does One Size Fit All?”

November 2011

Volume 17, Issue S3

Pages S1–S73

  1. Supplements

    1. Top of page
    2. Supplements
    3. ILTS Course Syllabus
    4. Supplements
    1. Present state of immunosuppressive therapy in liver transplant recipients (pages S1–S9)

      Russell H. Wiesner and John J. Fung

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22410

    2. Hepatocellular carcinoma: Agents and concepts for preventing recurrence after curative treatment (pages S10–S12)

      Hans J. Schlitt and Andreas A. Schnitzbauer

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22411

    3. Immunosuppression in pediatric liver transplantation: Are little people different? (pages S13–S19)

      Anil Dhawan

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22422

    4. Hot-topic debate on hepatitis C virus: The type of immunosuppression matters (pages S20–S23)

      James F. Trotter

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22414

    5. Hot topic in hepatitis C virus research: The type of immunosuppression does not matter (pages S24–S28)

      Marina Berenguer

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22347

  2. ILTS Course Syllabus

    1. Top of page
    2. Supplements
    3. ILTS Course Syllabus
    4. Supplements
    1. The immunoreactive patient: Rejection and autoimmune disease (pages S29–S33)

      John O'Grady

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22413

  3. Supplements

    1. Top of page
    2. Supplements
    3. ILTS Course Syllabus
    4. Supplements
    1. Infections in immunocompromised hosts and organ transplant recipients: Essentials (pages S34–S37)

      Jay A. Fishman

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22378

    2. Metabolic syndrome: Is immunosuppression to blame? (pages S38–S42)

      Kymberly D. Watt

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22386

    3. Hot-topic debate on kidney function: Renal-sparing approaches are beneficial (pages S43–S49)

      François Durand

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22392

    4. Hot-topic debate on kidney function: Renal-sparing approaches are ineffective (pages S50–S53)

      John R. Lake

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22429

    5. Future prospects in immunosuppression for liver transplantation (pages S54–S59)

      John J. Fung, Jessica E. Bollinger, Charles Miller and Bijan Eghtesad

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22412

    6. Next level of immunosuppression: Drug/immune monitoring (pages S60–S65)

      Josh Levitsky

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22385

    7. The failure of immunosuppression withdrawal: Patient benefit is not detectable, inducible, or reproducible (pages S66–S68)

      Paige Porrett and Abraham Shaked

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22377

    8. Hot-topic debate on tolerance: Immunosuppression withdrawal (pages S69–S73)

      Alberto Sánchez-Fueyo

      Article first published online: 26 OCT 2011 | DOI: 10.1002/lt.22421

SEARCH

SEARCH BY CITATION